Affiliation:
1. Institute of Biochemistry of Federal Research Center of Fundamental and Translational Medicine
Abstract
This work shows the ability of apolipoprotein A-I to influence the activity of lysosomal glycosidases in the liver of mice in a model of BCG-induced tuberculous inflammation. The aim of the investigation was to study the activity of lysosomal glycosidases in the liver of mice using a model of BCG-induced tuberculous inflammation after intravenous administration of apolipoprotein A-I. Material and methods. The studies were performed on male CBA mice weighing 20-22 g. Disseminated tuberculous inflammation was modeled by a single intraperitoneal injection of 0.5 mg of BCG vaccine. The activity of lysosomal glycosidases was assessed spectrofluorimetrically by the content of hydrolysis products of the corresponding fluorogenic substrates. Results. Tuberculous inflammation led to a pronounced decrease in the activity of lysosomal glycosidases in the liver. Thus, β-galactosidase was decreased 2.3 times, β-glucosidase – 2.8 times, β-glucuronidase – 2.5 times compared with healthy animals. Intravenous injection of apolipoprotein A-I to animals against the background of BCG infection prevented a significant decrease in the enzymatic activity of glycosidases and these values practically did not differ from the control values. Conclusions. Enzymatic activity of lysosomal glycosidases in the group of mice with intravenous administration of apolipoprotein A-I against the background of BCG infection was 1.5–2 times higher than the corresponding indicators in the group of animals with BCG-infection without administration of apolipoprotein A-I, i.e. without treatment.
Publisher
Institute of Cytology and Genetics, SB RAS
Reference10 articles.
1. Rozenfeld P., Feriozzi S. Contribution of inflammatory pathways to Fabry disease pathogenesis. Mol. Genet. Metab. 2017;122(3):19–27. doi: 10.1016/j.ymgme.2017.09.004
2. Sumenkova D.V., Polyakov L.M., Panin L.E. Vliyanie kompleksa izoniazida s apolipoproteinom A-I na aktivnost' fermentov lizosom u myshei s model'yu tuberkuleznogo vospaleniya. Eksperim. i klin. farmakol. 2012;75(11):28–30. Sumenkova D.V., Polyakov L.M., Panin L.E. Influence of isoniazid complex with A-I apolipoprotein on activity of lysosomal enzymes in mice with tuberculous inflammation model. Eksperimental’naya i klinicheskaya farmakologiya = Experimental and Clinical Pharmacology. 2012;75(11):28–30. [In Russian].
3. Chua J., Vergne I., Master S., Deretic V. A tale of two lipids: Mycobacterium tuberculosis phagosome maturation arrest. Curr. Opin. Microbiol. 2004;7(1):71– 77. doi: 10.1016/j.mib.2003.12.011
4. Hmama Z., Sendide K., Talal A., Garcia R., Dobos K., Reiner N.E. Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1alpha,25-dihydroxyvitamin D3-phosphoinositide 3-kinase pathway. J. Cell. Sci. 2004;117(Pt. 10):2131–2140. doi: 10.1242/jcs.01072
5. Shkurupii V.A. Tuberkuleznyi granulematoz. Tsitofiziologiya i adresnaya terapiya. M.: Izd-vo RAMN, 2007. 536 s. Shkurupy V.A. Tuberculous granulomatosis. Cytophysiology and address therapy. Moscow, 2007. 536 c. [In Russian].
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献